Rtw Investments »

Ataibeckley shares owned by Rtw Investments

Quarter-by-quarter ownership of Ataibeckley (ATAI) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Ataibeckley

Tip: Access up to 7 years of quarterly data

All positions including Ataibeckley held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ataibeckley by Rtw Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.1M 2.0M 3.54

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Cg Oncology (CGON)
Celcuity (CELC)
Tango Therapeutics (TNGX)
Erasca (ERAS)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Cogent Biosciences (COGT)

View all positions for Rtw Investments

Top funds holding Ataibeckley

Deep Track Capital
Vanguard Capital Management
UBS Group
BlackRock
Susquehanna International
Adage Capital Partners GP
Millennium Management
Morgan Stanley
Candriam Luxembourg S.C.A.
Qube Research & Technologies
Foresite Capital Management VI
Geode Capital Management
Marshall Wace
Rtw Investments
Two Sigma Investments

View all funds holding Ataibeckley